Understanding the mechanisms through which chemerin regulates blood pressure and sympathetic activity could provide valuable insights for developing targeted therapies for hypertension and cardiovascular diseases linked to dysregulated sympathetic responses. Here, RARRES2 is linked to cardiovascular disorder.